JPRN-UMIN000049359招募中Unknown
Safety and Efficacy of slow low-dose oral immunotherapy Shimane version for patients with positive low-dose oral food challenge - Shimane-SLOIT 2022
Department of Pediatrics, Shimane University School of Medicine0 个研究点目标入组 200 人开始时间: 2022年10月28日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 16years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) severe anaphylaxis induced by oral food challenge 2) uncontrolled bronchial asthma or atopic dermatitis 3) Has malignancy, autoimmune disease, immunodeficiency, severe cardiac disease, or chronic infectious disease 4) Consecutive use of systemic corticosteroids or anticancer agents 5) Undergoing other immunotherapy
研究者
相似试验
招募中
不适用
Efficacy and safety of low-dose oral immunotherapy with heated milk powder in patients with severe milk allergyfood allergyJPRN-UMIN000046749ational Hospital Organization Sagamihara National Hospital20
招募中
不适用
efficacy and safety of allergen extract dropping therapy for severe peanut and nut (walnut) allergyfood allergyJPRN-UMIN000048007Yokohama Nishikage Clinic: kids and allergies20
招募中
不适用
Efficacy and safety of slow and rush oral immunotherapy for patients with food allergyFood allergyJPRN-UMIN000019699Kansai Medical University30
招募中
不适用
Simultaneously slow low dose oral immunotherapyJPRN-UMIN000041561Aichi Children's Health and Medical Center30
进行中（未招募）
1 期
Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg.Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.EUCTR2006-005797-44-HUInstitut de Recherches Internationales Servier1,500